Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

Mapping transcription factor interactome networks using HaloTag protein arrays.

Proc. Natl. Acad. Sci. U.S.A.
Yazaki J, Galli M, Kim AY, Nito K, Aleman F, Chang KN, Carvunis AR, Quan R, Nguyen H, Song L, Alvarez JM, Huang SC, Chen H, Ramachandran N, Altmann S, Gutiérrez RA, Hill DE, Schroeder JI, Chory J, LaBaer J, Vidal M, Braun P, Ecker JR.
| Jun 29, 2016
3.

The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.

Nat. Genet.
Gibson WJ, Hoivik EA, Halle MK, Taylor-Weiner A, Cherniack AD, Berg A, Holst F, Zack TI, Werner HM, Staby KM, Rosenberg M, Stefansson IM, Kusonmano K, Chevalier A, Mauland KK, Trovik J, Krakstad C, Giannakis M, Hodis E, Woie K, Bjorge L, Vintermyr OK, Wala JA, Lawrence MS, Getz G, Carter SL, Beroukhim R, Salvesen HB.
| Jun 27, 2016
4.

Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia.

Nat. Med.
Li S, Garrett-Bakelman FE, Chung SS, Sanders MA, Hricik T, Rapaport F, Patel J, Dillon R, Vijay P, Brown AL, Perl AE, Cannon J, Bullinger L, Luger S, Becker M, Lewis ID, To LB, Delwel R, Löwenberg B, Döhner H, Döhner K, Guzman ML, Hassane DC, Roboz GJ, Grimwade D, Valk PJ, D'Andrea RJ, Carroll M, Park CY, Neuberg D, Levine R, Melnick AM, Mason CE.
| Jun 20, 2016
5.

Longitudinal multiparameter assay of lymphocyte interactions from onset by microfluidic cell pairing and culture.

Proc. Natl. Acad. Sci. U.S.A.
Dura B, Servos MM, Barry RM, Ploegh HL, Dougan SK, Voldman J.
| Jun 28, 2016
6.

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

N. Engl. J. Med.
Kantarjian HM, DeAngelo DJ, Stelljes M, Martinelli G, Liedtke M, Stock W, Gökbuget N, O'Brien S, Wang K, Wang T, Paccagnella ML, Sleight B, Vandendries E, Advani AS.
| Jun 12, 2016
7.

Universality of human microbial dynamics.

Nature.
Bashan A, Gibson TE, Friedman J, Carey VJ, Weiss ST, Hohmann EL, Liu YY.
| Jun 9, 2016
8.

Scaling identity connects human mobility and social interactions.

Proc. Natl. Acad. Sci. U.S.A.
Deville P, Song C, Eagle N, Blondel VD, Barabási AL, Wang D.
| Jun 28, 2016
9.

Responding to a Request for Physician-Assisted Death--Reply.

JAMA.
Quill TE, Back AL, Block SD.
| Jun 7, 2016
10.

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases.

Nat. Med.
Ni J, Ramkissoon SH, Xie S, Goel S, Stover DG, Guo H, Luu V, Marco E, Ramkissoon LA, Kang YJ, Hayashi M, Nguyen QD, Ligon AH, Du R, Claus EB, Alexander BM, Yuan GC, Wang ZC, Iglehart JD, Krop IE, Roberts TM, Winer EP, Lin NU, Ligon KL, Zhao JJ.
| Jun 6, 2016
11.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

N. Engl. J. Med.
Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR.
| Jun 5, 2016
12.

Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits.

Cell.
Ulirsch JC, Nandakumar SK, Wang L, Giani FC, Zhang X, Rogov P, Melnikov A, McDonel P, Do R, Mikkelsen TS, Sankaran VG.
| Jun 2, 2016
13.

Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.

Nature.
Jia Y, Yun CH, Park E, Ercan D, Manuia M, Juarez J, Xu C, Rhee K, Chen T, Zhang H, Palakurthi S, Jang J, Lelais G, DiDonato M, Bursulaya B, Michellys PY, Epple R, Marsilje TH, McNeill M, Lu W, Harris J, Bender S, Wong KK, Jänne PA, Eck MJ.
| Jun 2, 2016
15.

Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.

Proc. Natl. Acad. Sci. U.S.A.
Li H, Wang S, Kong R, Ding W, Lee FH, Parker Z, Kim E, Learn GH, Hahn P, Policicchio B, Brocca-Cofano E, Deleage C, Hao X, Chuang GY, Gorman J, Gardner M, Lewis MG, Hatziioannou T, Santra S, Apetrei C, Pandrea I, Alam SM, Liao HX, Shen X, Tomaras GD, Farzan M, Chertova E, Keele BF, Estes JD, Lifson JD, Doms RW, Montefiori DC, Haynes BF, Sodroski JG, Kwong PD, Hahn BH, Shaw GM.
| Jun 14, 2016
16.

Landscape of tumor-infiltrating T cell repertoire of human cancers.

Nat. Genet.
Li B, Li T, Pignon JC, Wang B, Wang J, Shukla SA, Dou R, Chen Q, Hodi FS, Choueiri TK, Wu C, Hacohen N, Signoretti S, Liu JS, Liu XS.
| 05 30, 2016
17.

MEDICINE. Paying for future success in gene therapy.

Science.
Orkin SH, Reilly P.
| May 27, 2016
18.

CANCER. The cancer predisposition revolution.

Science.
Malkin D, Garber JE, Strong LC, Friend SH.
| May 27, 2016
19.

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.

Nature.
Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin ME, Auchus RJ, Sharifi N.
| May 26, 2016
20.

Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells.

Cell.
Jadhav U, Nalapareddy K, Saxena M, O'Neill NK, Pinello L, Yuan GC, Orkin SH, Shivdasani RA.
| Jun 2, 2016